KALV - Kalvista Pharmaceuticals - Stock Forecast

Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KALV is currently covered by 5 analysts with an average price target of $26.24. This is a potential upside of $17.48 (199.54%) from yesterday's end of day stock price of $8.76.

Kalvista Pharmaceuticals's activity chart (see below) currently has 30 price targets and 44 ratings on display. The stock rating distribution of KALV is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 49.69% with an average time for these price targets to be met of 362.25 days.

Highest price target for KALV is $28, Lowest price target is $20, average price target is $26.24.

Most recent stock forecast was given by ANDREW FEIN from HC WAINWRIGHT on 06-Dec-2024. First documented stock forecast 21-Sep-2018.

Currently out of the existing stock ratings of KALV, 23 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$20

$11.64 (139.23%)

$20

19 days ago
(06-Dec-2024)

5/11 (45.45%)

$10.27 (105.55%)

287

Buy

$28

$19.64 (234.93%)

$32

20 days ago
(05-Dec-2024)

3/16 (18.75%)

$18.83 (205.34%)

378

Buy

$20

3 months 16 days ago
(09-Sep-2024)

2/3 (66.67%)

$9 (81.82%)

706

Buy

$26

$17.64 (211.00%)

$30

1 years 5 months 15 days ago
(10-Jul-2023)

1/2 (50%)

$15.53 (148.33%)

135

Buy

$20

$11.64 (139.23%)

1 years 10 months 22 days ago
(03-Feb-2023)

0/2 (0%)

$12.13 (154.13%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KALV (Kalvista Pharmaceuticals) average time for price targets to be met?

On average it took 362.25 days on average for the stock forecasts to be realized with a an average price target met ratio 49.69

Which analyst has the current highest performing score on KALV (Kalvista Pharmaceuticals) with a proven track record?

PAUL MATTEIS

Which analyst has the current lower performing score on KALV (Kalvista Pharmaceuticals) with a proven track record?

JOSEPH SCHWARTZ

Which analyst has the most public recommendations on KALV (Kalvista Pharmaceuticals)?

Paul Matteis works at STIFEL and has 17 price targets and 11 ratings on KALV

Which analyst is the currently most bullish on KALV (Kalvista Pharmaceuticals)?

Zegbeh Jallah with highest potential upside - $46.64

Which analyst is the currently most reserved on KALV (Kalvista Pharmaceuticals)?

Charles Duncan with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?